Latest News

  • Alkermes' Corporate Presentation to be Webcast at the 36th Annual J.P. Morgan Healthcare Conference Read More
  • Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis Read More
  • Alkermes Named a Top Place to Work by The Boston Globe Read More

Investors

Working at Alkermes